Moderna reaches "landmark moment" in Melanoma vaccine trial
CBS News medical correspondent Dr. Céline Gounder joins "The Daily Report" to discuss what Moderna's melanoma vaccine breakthrough could mean as clinical trials continue.
We haven't written up this one. CBS News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Promising Results for mRNA Cancer Vaccine from Moderna and Merck time.com
- Moderna and Merck shares soar on mRNA cancer vaccine axios.com
- Moderna, Merck breakthrough could usher in wave of cancer vaccines japantimes.co.jp
- How Moderna's melanoma mRNA vaccine could fight deadliest skin cancer cbsnews.com
- Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck seekingalpha.com
